Rate of Consumption as a Marker for Alcohol Use Disorder Risk: Evidence From a Human Laboratory Model

被引：0
|
作者：
Gowin, Joshua [1 ]
Sloan, Matthew [1 ]
Stangl, Bethany [1 ]
Stoddard, Joel [1 ]
Vatsalya, Vatsalya [1 ]
Ramchandani, Vijay [1 ]
机构：
[1] NIAAA, Bethesda, MD USA
来源：
NEUROPSYCHOPHARMACOLOGY | 2016年 / 41卷
关键词：
Alcohol Consumption; IV Alcohol; Alcohol Self-Administration; Alcohol use Disorder;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
M233
引用
收藏
页码：S266 / S267
页数：2
相关论文
共 50 条
  • [21] "Evidence" and the Treatment of Alcohol Use Disorder
    Howland, Robert H.
    JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES, 2015, 53 (05) : 11 - 14
  • [22] Diverse types of genomic evidence converge on alcohol use disorder risk genes
    Dai, Yulin
    Hu, Ruifeng
    Pei, Guangsheng
    Zhang, Huiping
    Zhao, Zhongming
    Jia, Peilin
    JOURNAL OF MEDICAL GENETICS, 2020, 57 (11) : 733 - 743
  • [23] EFFECTS OF VARENICLINE IN HUMAN LABORATORY MODELS FOR SCREENING OFPHARMACOTHERAPEUTICS FOR ALCOHOL USE DISORDER.
    Vatsalya, V.
    Gowin, J. L.
    Schwandt, M. L.
    Momenan, R.
    Heilig, M.
    Bardett, S. E.
    Ramchandani, V. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 : S21 - S21
  • [24] Patterns of alcohol consumption in european pregnant women with alcohol use disorder
    Pereira, I.
    Nogueira, V.
    Teixeira, J.
    EUROPEAN PSYCHIATRY, 2021, 64 : S557 - S557
  • [25] CONVERGING EVIDENCE FROM RODENT AND HUMAN STUDIES ON THE ROLE OF SPIRONOLACTONE AS A POTENTIAL PHARMACOTHERAPY FOR ALCOHOL USE DISORDER
    Farokhnia, Mehdi
    Rentsch, Christopher T.
    Chuong, Vicky
    McGinn, M. Adrienne
    Elvig, Sophie K.
    Douglass, Eliza A.
    Gonzalez, Luis A.
    Sanfilippo, Jenna E.
    Marchette, Renata C. N.
    Tunstall, Brendan J.
    Fiellin, David A.
    Koob, George F.
    Justice, Amy C.
    Leggio, Lorenzo
    Vendruscolo, Leandro F.
    ALCOHOL, 2023, 109 : 83 - 84
  • [26] Spironolactone as a potential new pharmacotherapy for alcohol use disorder: convergent evidence from rodent and human studies
    Farokhnia, Mehdi
    Rentsch, Christopher T.
    Chuong, Vicky
    McGinn, M. Adrienne
    Elvig, Sophie K.
    Douglass, Eliza A.
    Gonzalez, Luis A.
    Sanfilippo, Jenna E.
    Marchette, Renata C. N.
    Tunstall, Brendan J.
    Fiellin, David A.
    Koob, George F.
    Justice, Amy C.
    Leggio, Lorenzo
    Vendruscolo, Leandro F.
    MOLECULAR PSYCHIATRY, 2022, 27 (11) : 4642 - 4652
  • [27] DOES DELAY DISCOUNTING PREDICT ALCOHOL CONSUMPTION IN A HUMAN LABORATORY MODEL OF IMPAIRED CONTROL?
    Rung, J. M.
    Gebru, N. M.
    Berey, B. L.
    Frohe, T.
    O'Malley, S. S.
    Leeman, R. F.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2022, 46 : 107A - 107A
  • [28] Spironolactone as a potential new pharmacotherapy for alcohol use disorder: convergent evidence from rodent and human studies
    Mehdi Farokhnia
    Christopher T. Rentsch
    Vicky Chuong
    M. Adrienne McGinn
    Sophie K. Elvig
    Eliza A. Douglass
    Luis A. Gonzalez
    Jenna E. Sanfilippo
    Renata C. N. Marchette
    Brendan J. Tunstall
    David A. Fiellin
    George F. Koob
    Amy C. Justice
    Lorenzo Leggio
    Leandro F. Vendruscolo
    Molecular Psychiatry, 2022, 27 : 4642 - 4652
  • [29] Alcohol Use Disorder Among Textile Workers: Evidence from Ethiopia
    Belete, Habte
    Belete, Tilahun
    Bacharach, Samuel
    Briggs, Kathleen Ann
    Bamberger, Peter
    JOURNAL OF DRUG ISSUES, 2024, 54 (04) : 560 - 575
  • [30] Determinants of alcohol use in pregnant women at risk for alcohol consumption
    Haynes, G
    Dunnagan, T
    Christopher, S
    NEUROTOXICOLOGY AND TERATOLOGY, 2003, 25 (06) : 659 - 666
12345